Greater Copenhagen Health Science Partners

What Greater Copenhagen Health Science Partners does

Greater Copenhagen Health Science Partners (GCHSP) is a publicly funded translational health research consortium headquartered in Copenhagen, Denmark, formally launched in 2020. It was established as a four-party partnership between the University of Copenhagen, the Technical University of Denmark (DTU), Region Zealand, and the Capital Region of Denmark, with the stated mission of accelerating the translation of basic laboratory research into clinical practice by directly connecting university researchers with hospital clinicians. GCHSP's core operating unit is the Clinical Academic Group (CAG): cross-disciplinary research programs led by a Chair and Vice Chair, with Junior Chairs, Key Members, and PhD/postdoctoral researchers, that operate semi-independently within the four partner institutions. As of 2025 the consortium coordinates 27 CAGs covering allergy, cardiology, hematology, oncology, inflammation, infectious disease, digital health, women's health, cell and gene therapy, and aging, among other areas, with 52 or more PhD and postdoctoral researchers embedded across the network.

GCHSP does not sell products or services; its economic model is grant-based and institutionally funded. Each appointed CAG receives a structured 3 million DKK grant (1.5 million DKK disbursed to the Chair upon appointment for research-facilitating expenses, and a further 1.5 million DKK upon filling three PhD/postdoc positions), supplemented by the in-kind contributions of the four partner institutions — faculty time, hospital infrastructure, and shared facilities. Individual CAGs additionally attract external grant funding, exemplified by the 11.8 million DKK Novo Nordisk Foundation Tandem grant awarded to CAG SURF in 2025 for 3D bioprinting and tissue regeneration research. CAG HEMATOLOGY has built a biobank of more than 2,500 patient samples linked to a clinical database. New CAGs are appointed by the Executive Board after open calls evaluated by an international academic panel, and CAGs engage with international networks such as the European Hematology Association's Topics-in-Focus program.

The consortium's go-to-market is institutional rather than commercial: research outputs are disseminated through the gchsp.dk website, the annual Research & Innovation Conference, public symposia such as the ATMP Symposium 2026, and 27 published CAG impact posters. The end beneficiaries are patients within the Capital Region of Denmark and Region Zealand, with the consortium's value proposition centered on faster implementation of research findings into patient care, improved access to data and patients for researchers, and a flexible collaborative structure that crosses traditional organizational boundaries.

Name

Greater Copenhagen Health Science Partners

Legal name

Greater Copenhagen Health Science Partners

Website

https://gchsp.dk

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Greater Copenhagen Health Science Partners is a publicly funded translational research consortium launched in 2020 by the University of Copenhagen, DTU, Region Zealand, and the Capital Region of Denmark. It coordinates 27 Clinical Academic Groups that bridge university researchers and hospital clinicians to speed health research into patient care across Eastern Denmark.

Ownership category

akta.pro rank

Product category

Translational Health Research Partnership

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industries

Health & Medical Research Grantmaking Foundations (BPAGAKAL), Public–Private Partnerships (PPPs) for Global Health (HLAJAOAD), Research Collaboration & Joint Labs (International Partnerships) (EDAIABAC)

Keywords

• Translational health research
• Clinical academic groups
• Biomedical research partnership
• University hospital collaboration
• Health science consortium

Headquarters

HQ city

Copenhagen

HQ country

Denmark

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Pricing tiers

Distribution channels1 record

Marketing channels4 records

Core offering

GCHSP coordinates a translational health research partnership that bridges university-based basic scientists and hospital-based clinicians through 27 Clinical Academic Groups (CAGs), each focused on a specific disease area or research theme. The consortium distributes grant funding (3 million DKK per CAG), supports PhD and postdoctoral researchers, and integrates research, clinical practice, and postgraduate training across four Danish partner institutions. Outputs include research collaborations, biobank assets, publications, and an annual research and innovation conference.

Product overview

Greater Copenhagen Health Science Partners (GCHSP) operates as a research partnership network rather than a traditional product company. The organization coordinates 27 Clinical Academic Groups (CAGs) - cross-disciplinary research programs that bridge university researchers and hospital clinicians. CAGs function as semi-independent research units focused on specific disease areas or healthcare challenges, each led by a CAG Chair and Vice Chair, with Junior Chairs and Key Members. The CAGs cover diverse health research domains including cancer, cardiovascular disease, immunology, inflammation, digital health, and aging. GCHSP itself serves as the coordinating infrastructure connecting four partner organizations: University of Copenhagen, Technical University of Denmark (DTU), Region Zealand, and the Capital Region of Denmark.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Academic Groups (CAG) Programme Cross-institutional translational research programme coordinating 27 Clinical Academic Groups (CAGs) that pair university basic researchers with hospital clinicians across disease areas such as allergy, cardiology, hematology, oncology, inflammation, osteoarthritis, skin cancer, and infectious diseases; each CAG receives 3 million DKK in grant funding and operates under joint clinical and academic leadership with quality evaluation by an international panel.
• CAG PhD and Postdoc Programme Doctoral and postdoctoral research positions embedded within each Clinical Academic Group, with 1.5 million DKK per CAG disbursed when three PhD/postdoc positions are filled, supporting 52+ early-career researchers bridging basic science and clinical practice.
• Six New Clinical Academic Groups (WHIP, ATMP, PRECISE-IBD, DIGITAL, HOME, VAX) New Clinical Academic Groups appointed to expand GCHSP from 21 to 27 CAGs, addressing women's health (WHIP), cell and gene therapy integration (ATMP), inflammatory bowel disease precision medicine (PRECISE-IBD), digital phenotyping for home-based care (DIGITAL), home treatment implementation (HOME), and vaccine research for high-risk adults (VAX).
• Translational Hematology (CAG HEMATOLOGY) Biobank and Clinical Database High-quality blood and bone marrow biobank samples from more than 2,500 patients, paired with a comprehensive clinical database, supporting CAG HEMATOLOGY precision medicine research in blood cancer.
• ATMP SYMPOSIUM 2026: From Innovation to Implementation Public symposium focused on gene and cell therapies in Danish healthcare systems, organized by CAG-ATMP, hosted at Rigshospitalet, with free admission and registration required, bringing together science, healthcare, ethics and society stakeholders to accelerate advanced therapy medicinal product implementation.

Quantifiable outcome

• 3 million DKK in grant funding per CAG distributed across research-facilitating expenses and PhD/postdoc positions
• +2 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and minor.

• University of Copenhagen (Københavns Universitet)coreStrategic or Co-development PartnerUniversity of Copenhagen is one of four founding partners in GCHSP. The partnership aims to strengthen cooperation between basic laboratory researchers and clinical hospital researchers. The university provides faculty resources, research infrastructure, and academic leadership through CAG Chairs, Vice Chairs, and key members across all 27 CAGs.
• Technical University of Denmark (DTU)coreStrategic or Co-development PartnerDTU is one of four founding partners in GCHSP. Contributes technical and engineering expertise across health technology, bioengineering, and computational research. DTU provides faculty leadership including CAG Vice Chairs and key members in CAGs such as ATMP, DIGITAL, and SURF.
• Capital Region of Denmark (Region Hovedstaden)coreStrategic or Co-development PartnerCapital Region of Denmark is one of four founding partners, providing hospital-based clinical research environments. Rigshospitalet, Hvidovre Hospital, Bispebjerg Hospital, Herlev Hospital, and other regional hospitals contribute clinicians, CAG Chairs, and clinical infrastructure for translational research.
• Region Zealand (Region Sjælland)coreStrategic or Co-development PartnerRegion Zealand is one of four founding partners, contributing hospital and healthcare research environments from facilities including Zealand University Hospital. Provides regional clinical leadership across multiple CAGs including ROAD, ACUTE, and others.
• European Hematology Association (EHA)minorStrategic or Co-development PartnerCAG HEMATOLOGY participates in EHA's Topics-in-Focus program, which arranges meetings and preceptorships. CAG HEMATOLOGY's work aligns with EHA's precision hematology initiatives.

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• King's Health Partners: London-based Academic Health Sciences Centre integrating King's College London, Guy's and St Thomas', King's College Hospital, and South London and Maudsley NHS Foundation Trust — a multi-institutional translational research partnership operating under a similar governance and CAG-equivalent program model.
• Oslo University Hospital: Norway's largest hospital and a translational research hub combining clinical care with university-linked research groups — comparable Nordic regional translational research partnership analogous to GCHSP.
• UCL Partners: Academic Health Science Partnership comprising UCL, University College London Hospital, Barts Health, Great Ormond Street Hospital, and other NHS trusts — directly comparable as an urban multi-institution translational research consortium.
• Cambridge University Health Partners: Designated UK Academic Health Science Centre linking the University of Cambridge with Cambridge University Hospitals and other regional partners to accelerate translational health research — structurally analogous to GCHSP's university-region partnership model.
• Imperial College Health Partners: Designated UK Academic Health Science Network anchored by Imperial College London and Imperial College Healthcare NHS Trust — a multi-institution translational research partnership aligned with GCHSP's clinical–academic integration model.
• Manchester Academic Health Science Centre (MAHSC): UK AHSC partnership between the University of Manchester and major NHS trusts in Greater Manchester, coordinating translational research across disease themes — structurally aligned with GCHSP's CAG-style model.

Broad incumbents

• Erasmus MC: Rotterdam-based university medical center combining research, education, and patient care with strong international collaboration — a broader, more established translational research institution than GCHSP but operating in a comparable role within its regional ecosystem.
• Karolinska Institutet: Sweden's largest medical university, deeply integrated with Karolinska University Hospital; a broader and more established Nordic translational research institution, but operating under a similar university–hospital integration model that GCHSP embodies at smaller scale.
• Leiden University Medical Center (LUMC): Major Dutch university medical center integrating biomedical research, medical education, and clinical care — comparable to GCHSP's translational research orientation though operating as a single institution rather than a multi-party partnership.

Regional players

• Helsinki University Hospital (HUS): Finland's largest hospital and a translational research partner of the University of Helsinki — a Nordic regional university-hospital translational research platform comparable to GCHSP's regional partnership scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/greater-copenhagen-health-science-partners

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Greater Copenhagen Health Science Partners